Skip to content

Velox™

World class cancer assay diagnostic test.

This is a CA test that tags and monitors circulating tumor cells (CTC) in the body. The Velox™ test can capture individual cancer cells that are within 2-30 microns in size. The problem with relying on current imaging systems is that they can only detect solid tumors of 1mm or greater in size. Ideally Velox™ is used for patients with metastatic (advanced stage) cancers:

  • Breast
  • Lung
  • Ovarian
  • Prostate
  • Colorectal
  • Kidney
  • Melanoma
  • Leukemia
  • Pancreatic

 

A blood sample is drawn and used in a process that counts CTCs – with a 95% rate of accuaracy. Velox™ offers results within an hour, and is far more affordable than the more commonly used CA125 test, which takes up to 4 hours and only measure protein levels.

It is recommended that physicians administer the Velox™ test every 30 days. If the patient’s CTC levels are at 25 or more, it is suggested that a change in treatment is considered.

IV Diagnostics has a Provisional Patent on the Velox™ test.

hourglass

Real time results in under one hour

“We appreciate that there are many different therapies for cancer, and successful treatments will depend on a better understanding of circulating tumor cells that can cause metastases. We believe that IVDiagnostics has the platform technology to rapidly detect and monitor these cells to inform therapeutic approaches.”

Scroll To Top